Silverstone Research
Las Vegas, Nevada, 89146, United States
NCT Number: NCT06659471
The objective of this learning clinical study is to evaluate the effects of formulation chemistry on gingivitis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Las Vegas, Nevada, 89146, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Whole mouth brushing with a toothpaste, twice daily for the duration of the study.
Whole mouth brushing with a toothpaste, twice daily for the duration of the study.
Time frame: 3 months, 1 month
Number of bleeding sites derived from the Löe-Silness Gingivitis Evaluation based on a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).
Time frame: 3 months, 1 month
Löe-Silness Gingivitis Evaluation is a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).
Procter and Gamble
Industry
A Three-Month Bleeding Model Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715331
Esthetics, Dental, Excessive Gingival Display
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07691060
Arachnodactyly, Congenital Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07591142
Gingival Diseases, Gingival Recession
Damascus, Syria
View Trial DetailsNCT06029283
Cardiovascular Diseases, Gingival Bleeding
Baltimore, Maryland, United States
View Trial Details